Overview An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors Status: Completed Trial end date: 2017-01-01 Target enrollment: Participant gender: Summary This is an extension study of ABT-806 for subjects with advanced solid tumors. Phase: Phase 1 Details Lead Sponsor: AbbVie (prior sponsor, Abbott)